Drug Sponsors

Roche disappointed with ISS recommendation

Monday, April 9, 2012 09:19 AM

The Institutional Shareholder Services (ISS) has recommended that shareholders of Illumina vote against the election of Roche’s independent director nominees to Illumina’s board of directors.

More... »

Biocon opens research center in India, seeks 300 scientists

Friday, April 6, 2012 01:00 PM

Biocon, an Asia-based biotech, has opened the doors of its Integrated Research and Development Centre, Biocon Research Centre (BRC) in India, aimed at pursuing world class research on biologics that will address unmet medical needs.

More... »

Cerecor raises $22 million Series A financing

Friday, April 6, 2012 12:25 PM

Cerecor, a newly formed Baltimore biotech focused on translational medicine for the nervous system, has raised over $22 million in an overallotment of its January 2012 Series A preferred stock financing.

More... »

Takeda joins SGC, funds drug research

Friday, April 6, 2012 11:34 AM

Takeda Pharmaceutical has joined the Structural Genomics Consortium (SGC), based at the Universities of Toronto and Oxford, England, to fund collective drug research aimed at bringing new, more effective medicines to market faster.

More... »

Spectrum to acquire Allos Therapeutics

Friday, April 6, 2012 10:32 AM

Spectrum Pharmaceuticals, a biotechnology company specializing in oncology and hematology, has signed an agreement to acquire all outstanding shares of Allos Therapeutics, a biopharmaceutical company of anti-cancer therapeutics, for $1.82 per share in cash plus one Contingent Value Right (CVR).

More... »

Burrill wraps up life sciences industry for Q1 2012

Wednesday, April 4, 2012 03:00 PM

Burrill & Company, a diversified global financial services firm focused on the life sciences industry, has identified more than $2.6 billion in expected funding through nine translational research and early-stage initiatives announced since the end of February.

More... »

Valeant moves global headquarters to Quebec

Wednesday, April 4, 2012 01:48 PM

Valeant Pharmaceuticals International is moving its global headquarters to the Montreal region and establishing an R&D center of excellence for consumer dermatologyin nearby Laval, Quebec.

More... »

Sigma-Aldrich acquires Research Organics

Wednesday, April 4, 2012 10:53 AM

Sigma-Aldrich, a life science and high technology company, has acquired all outstanding shares of Cleveland-based Research Organics, a supplier of high purity biochemicals.

More... »

Adimab completes series F funding, begins expansion

Wednesday, April 4, 2012 10:32 AM

Adimab, a discovery company of fully human antibodies, has closed its over-subscribed Series F financing and acquired a research facility in Lebanon, N.H., where it plans to set up new headquarters.

More... »

Amgen, AstraZeneca to develop and commercialize inflammation portfolio

Monday, April 2, 2012 04:38 PM

Amgen and AstraZeneca have agreed to jointly develop and commercialize five monoclonal antibodies from Amgen's clinical inflammation portfolio (AMG 139, AMG 157, AMG 181, AMG 557 and brodalumab (AMG 827)).

More... »